GEN and GNMSF Related Headlines

Go Back

GEN and GNMSF Related Press Releases

Go Back

May 17, 2013 06:51AM Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
May 7, 2013 11:08AM Genmab Announces Financial Results for the First Quarter of 2013
May 1, 2013 12:56PM Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia
May 1, 2013 11:52AM Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration
Apr 24, 2013 07:11AM Arzerra First Quarter 2013 Net Sales Figures
Apr 17, 2013 10:19AM Passing of Genmab A/S' Annual General Meeting
Apr 16, 2013 02:20PM Genmab Announces Final US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit
Apr 2, 2013 10:26AM Daratumumab Granted Fast Track Designation From U.S. Food and Drug Administration
Mar 25, 2013 02:14AM Arzerra Receives Approval in Japan

GEN and GNMSF Related SEC Filings

Go Back